
Gilead Sciences (GILD) is a component of the iShares MSCI USA ESG Select ETF (SUSA) and the iShares MSCI KLD 400 Social Index Fund ETF (DSI), with weightings of 1.10% and 0.50%, respectively. The company's annualized dividend is $3.16 per share, paid quarterly, with the most recent ex-date on 06/13/2025; dividend history is considered a key factor in assessing the sustainability of future payouts.
Gilead Sciences (GILD) is a constituent in ESG-focused ETFs, holding a 1.10% weight in the iShares MSCI USA ESG Select ETF (SUSA) and 0.50% in the iShares MSCI KLD 400 Social Index Fund ETF (DSI), underscoring its ESG credentials. The company provides an annualized dividend of $3.16 per share, paid quarterly, with a reported recent ex-dividend date of 06/13/2025. The emphasis on its dividend history as a key indicator for future payout sustainability is significant for income-oriented investors. Operating within the Biotechnology sector, alongside peers such as Amgen Inc (AMGN) and Thermo Fisher Scientific Inc (TMO), GILD's characteristics appear to align with criteria for socially responsible dividend investments. The associated sentiment is mildly positive (0.25 overall, 0.2 for GILD), though the immediate market impact is considered low (0.1), suggesting these factors are supportive but may not be primary drivers of short-term price action.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment